Role of cyclic guanosine monophosphate and K+ channels as mediators of the mesenteric vascular hyporesponsiveness in portal hypertensive rats

被引:19
作者
Atucha, NM [1 ]
Ortíz, MC [1 ]
Fortepiani, LA [1 ]
Ruiz, FM [1 ]
Martínez, C [1 ]
García-Estan, J [1 ]
机构
[1] Univ Murcia, Fac Med, Dept Fisiol, E-30100 Murcia, Spain
关键词
D O I
10.1002/hep.510270402
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The mechanisms mediating the hyporesponsiveness to vasoconstrictors in portal hypertension are not completely established, In the present study, we evaluated the role of cyclic guanosine monophosphate (cGMP) and potassium channels as contributors to the presser hyporesponsiveness to methoxamine (MTX) of the mesenteric vascular bed of portal vein-ligated (PVL) hypertensive rats. In basal conditions, and compared with sham-operated control rat (SHAM) vessels, PVL preparations showed a blunted presser response (maximum: 39.3 +/- 6.1 vs. 94.5 +/- 8.9 mm Hg), which increased by pretreatment with methylene blue (MB), a guanylate cyclase inhibitor (118.7 +/- 8.9 vs, 152.0 +/- 10.0, respectively), and even more with the nitric oxide (NO) synthesis inhibitor N-omega-nitro-L-arginine (NNA) (159.9 +/- 7.4 vs. 194.1 +/- 5.7, respectively), suggesting that NO acts through cGMP-dependent and independent mechanisms. In all cases, however, the presser responses of PVL vessels were lower than those of SHAM. Pretreatment of the vessels with the potassium channel inhibitors, tetraethylammonium (TEA), glibenclamide (GLB), or charybdotoxin (CHX), did not improve the reduced presser responses of the PVL rats, However, when the preparations were simultaneously pretreated with MB and TEA or with NNA and TEA, the presser responses were potentiated with respect to groups treated with MB or NNA alone, and the differences between PVL and SHAM vessels were completely corrected. These data suggest that both NO and potassium channels mediate the vascular hyporesponsiveness to methoxamine of the PVL mesenteric vasculature. Our results also disclose that NO blunts the presser response of the PVL vessels by a dual mechanism of action, through activation of potassium channels and through the formation of cGMP. Finally the NO-independent component mediated by potassium channels can be only seen when the main cGMP-NO component is inactivated. In conclusion, both cGMP and potassium channels mediate the vascular hyporesponsiveness to MTX of the mesenteric bed of portal hypertensive rats.
引用
收藏
页码:900 / 905
页数:6
相关论文
共 32 条
[1]   VARYING EXTRACELLULAR [K+] - A FUNCTIONAL-APPROACH TO SEPARATING EDHF-RELATED AND EDNO-RELATED MECHANISMS IN PERFUSED RAT MESENTERIC ARTERIAL BED [J].
ADEAGBO, ASO ;
TRIGGLE, CR .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1993, 21 (03) :423-429
[2]   Role of protein kinase C in mesenteric pressor responses of rats with portal hypertension [J].
Atucha, NM ;
Ortiz, MC ;
Martinez, C ;
Quesada, T ;
GarciaEstan, J .
BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (02) :277-282
[3]   Role of endothelium in the abnormal response of mesenteric vessels in rats with portal hypertension and liver cirrhosis [J].
Atucha, NM ;
Shah, V ;
GarciaCardena, G ;
Sessa, WE ;
Groszmann, RJ .
GASTROENTEROLOGY, 1996, 111 (06) :1627-1632
[4]   Nitric oxide attenuates the release of endothelium-derived hyperpolarizing factor [J].
Bauersachs, J ;
Popp, R ;
Hecker, M ;
Sauer, E ;
Fleming, I ;
Busse, R .
CIRCULATION, 1996, 94 (12) :3341-3347
[5]   NITRIC-OXIDE DIRECTLY ACTIVATES CALCIUM-DEPENDENT POTASSIUM CHANNELS IN VASCULAR SMOOTH-MUSCLE [J].
BOLOTINA, VM ;
NAJIBI, S ;
PALACINO, JJ ;
PAGANO, PJ ;
COHEN, RA .
NATURE, 1994, 368 (6474) :850-853
[6]   REGULATION AND FUNCTIONAL CONSEQUENCES OF ENDOTHELIAL NITRIC-OXIDE FORMATION [J].
BUSSE, R ;
FLEMING, I .
ANNALS OF MEDICINE, 1995, 27 (03) :331-340
[7]   IMPAIRED RESPONSIVENESS TO ANGIOTENSIN-II IN EXPERIMENTAL CIRRHOSIS - ROLE OF NITRIC-OXIDE [J].
CASTRO, A ;
JIMENEZ, W ;
CLARIA, J ;
ROS, J ;
MARTINEZ, JM ;
BOSCH, M ;
ARROYO, V ;
PIULATS, J ;
RIVERA, F ;
RODES, J .
HEPATOLOGY, 1993, 18 (02) :367-372
[8]   INCREASED NITRIC OXIDE-DEPENDENT VASORELAXATION IN AORTIC RINGS OF CIRRHOTIC RATS WITH ASCITES [J].
CLARIA, J ;
JIMENEZ, W ;
ROS, J ;
RIGOL, M ;
ANGELI, P ;
ARROYO, V ;
RIVERA, F ;
RODES, J .
HEPATOLOGY, 1994, 20 (06) :1615-1621
[9]   FLOW ACTIVATES AN ENDOTHELIAL POTASSIUM CHANNEL TO RELEASE AN ENDOGENOUS NITROVASODILATOR [J].
COOKE, JP ;
ROSSITCH, E ;
ANDON, NA ;
LOSCALZO, J ;
DZAU, VJ .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (05) :1663-1671
[10]  
EDWARDS G, 1993, ANNU REV PHARMACOL, V33, P597, DOI 10.1146/annurev.pharmtox.33.1.597